Pronutria names new CMO
This article was originally published in Scrip
Cambridge, Massachusetts-based Pronutria Biosciences, a biotechnology company developing a new class of therapeutics to mediate amino acid biology, has named Dr Christopher Wright senior vice-president and chief medical officer. Dr Wright will lead the company's global clinical development and medical affairs. Prior to joining Pronutria Biosciences, he was senior vice-president and head of global medicine development and affairs at Vertex Pharmaceuticals, where he led global development functions across all therapeutic areas of clinical development, medical affairs, clinical operations, medical writing, biometrics, regulatory affairs and patient safety.